| 000 | 01845 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516063246.0 | ||
| 264 | 0 | _c20120327 | |
| 008 | 201203s 0 0 eng d | ||
| 022 | _a1998-4049 | ||
| 024 | 7 |
_a10.4103/1319-3767.87183 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEl-Atrebi, Kamal A | |
| 245 | 0 | 0 |
_aSexual dysfunction in males with hepatitis C virus: relevance to histopathologic changes and peginterferon treatment. _h[electronic resource] |
| 260 |
_bSaudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association _c |
||
| 300 |
_a406-10 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBiopsy, Needle |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 |
_aEgypt _xepidemiology |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHepacivirus _xgenetics |
| 650 | 0 | 4 |
_aHepatitis C Antibodies _xanalysis |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 |
_aLiver _xpathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xtherapeutic use |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRNA, Viral _xanalysis |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 |
_aSexual Dysfunction, Physiological _xepidemiology |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aEl-Atrebi, Mohamed A | |
| 700 | 1 | _aEl-Bassyouni, Hala T | |
| 773 | 0 |
_tSaudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association _gvol. 17 _gno. 6 _gp. 406-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4103/1319-3767.87183 _zAvailable from publisher's website |
| 999 |
_c21293876 _d21293876 |
||